Targeted Translation Research Accelerator (TTRA) Round 2 – Device Funding

The Targeted Translation Research Accelerator (TTRA) Round 2 Devices can provide up to $1m non-dilutive investment to help SMEs, accelerate into practice promising medical devices that reduce the burden of cardiovascular disease and complications of diabetes for patients, carers, families and communities.

The TTRA is delivered in conjunction with MTPConnect and forms part of the Federal Governments, Medical Research Future Fund (MRFF).  And along with the financial support also comes other support provided by other accelerators.

There is a funding match requirement. 

TTRA funding of between $200,000 – $500,000 requires matched funding of 1:4.  For example, TTRA Investment = $450,000, requires at least $112,500 in funding for a total project of $562,000

TTRA funding of between $500,001 – $1,000,000 requires matched funding of 1:2.  For example, TTRA Investment = $750,000, requires at least $325,000 in funding for a total project of $1,175,000.

Eligibility for Round 2 Devices 

Eligible applicants include SMEs, start-ups, and spin-out companies that are working on medical devices to prevent, diagnose, treat or manage cardiovascular disease or complications of diabetes.   Key requirements include:

• being a for profit business with ess than 200 employees with an ABN.
• the product/solution must be a medical device that addresses cardiovascular disease or the complications of diabetes (type 1 or 2).
• The device must meet the Therapeutic Goods Administration definition of a medical device and be at least entering TRL4.
• control or have the legal right to access and use the relevant know-how and/or existing and/or potential intellectual property.

Application process

There are multiple phases in the application process.

Phase 0 Submit a Notice of Intent (NOI)

Phase I Expression of Interest (EOI)

Successful applicants will move to Phase II Due Diligence Consultation. 

Successful applicants will then move to Phase III Full Proposal:

Learn More

Click here to learn more and lodge you Notice of Intent for the Targeted Translation Research Accelerator (TTRA) Round 2 – Device Funding

Note applications close 30 March 2026

Contact Wayne on wayne@arealcfo.com.au or 0412 227 052.

Click on the below buttons to access free Resources developed by Wayne Wanders, A Real CFO to help your business scale and grow profitably

Want a confidential discussion on your business situation, help with your grant application or to learn more about my Outsourced CFO Services, simply email me at wayne@aRealCFO.com.au or call me on 0412 227 052